2-191009591-G-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_007315.4(STAT1):​c.128+285C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0559 in 152,158 control chromosomes in the GnomAD database, including 303 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.056 ( 303 hom., cov: 33)

Consequence

STAT1
NM_007315.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.132

Publications

3 publications found
Variant links:
Genes affected
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]
STAT1 Gene-Disease associations (from GenCC):
  • autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
  • immunodeficiency 31B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-191009591-G-T is Benign according to our data. Variant chr2-191009591-G-T is described in ClinVar as Benign. ClinVar VariationId is 1286087.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.174 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAT1NM_007315.4 linkc.128+285C>A intron_variant Intron 3 of 24 ENST00000361099.8 NP_009330.1 P42224-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAT1ENST00000361099.8 linkc.128+285C>A intron_variant Intron 3 of 24 1 NM_007315.4 ENSP00000354394.4 P42224-1

Frequencies

GnomAD3 genomes
AF:
0.0559
AC:
8501
AN:
152040
Hom.:
303
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0551
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0356
Gnomad ASJ
AF:
0.0784
Gnomad EAS
AF:
0.184
Gnomad SAS
AF:
0.141
Gnomad FIN
AF:
0.0362
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0474
Gnomad OTH
AF:
0.0512
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0559
AC:
8503
AN:
152158
Hom.:
303
Cov.:
33
AF XY:
0.0567
AC XY:
4221
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0550
AC:
2283
AN:
41498
American (AMR)
AF:
0.0356
AC:
544
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0784
AC:
272
AN:
3470
East Asian (EAS)
AF:
0.184
AC:
952
AN:
5174
South Asian (SAS)
AF:
0.141
AC:
678
AN:
4820
European-Finnish (FIN)
AF:
0.0362
AC:
383
AN:
10580
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0474
AC:
3224
AN:
68008
Other (OTH)
AF:
0.0517
AC:
109
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
414
829
1243
1658
2072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0524
Hom.:
366
Bravo
AF:
0.0549
Asia WGS
AF:
0.154
AC:
537
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.8
DANN
Benign
0.39
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41507345; hg19: chr2-191874317; API